Erratum: Editorial note: “Ultra-low-dose naloxone suppresses opioid tolerance, dependence, associated changes in mu opioid receptor–G protein coupling, Gβγ signalling” [Neuroscience 135(1)(2005)247–261] (Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor–G protein coupling and Gβγ signaling (2005) 135(1) (247–261), (S030645220500610X), (10.1016/j.neuroscience.2005.06.003));Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gβγ signaling

Neuroscience

Volumn 135, Issue 1, 2005, Pages 247-261

  Wang, H Y ^a   Friedman, E ^a   Olmstead, M C ^b   Burns, L H ^c  

^a CITY UNIVERSITY OF NEW YORK MEDICAL SCHOOL   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c Pain Therapeutics Inc ^*  (United States)

Author keywords

Adenylyl cyclase; Antinociception; Morphine; Signal transduction; Withdrawal

Indexed keywords

ADENYLATE CYCLASE; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN BETA SUBUNIT; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; OPIATE; OPIATE ANTAGONIST;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATTENUATION; BRAIN REGION; CELL ACTIVITY; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; DRUG TOLERANCE; ENZYME ACTIVATION; EXCITATION; HYPERALGESIA; HYPERPOLARIZATION; IN VITRO STUDY; LONG TERM EXPOSURE; LOW DRUG DOSE; MALE; MOLECULAR MECHANICS; NONHUMAN; OPIATE ADDICTION; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; PROTEIN INTERACTION; RAT; SIGNAL TRANSDUCTION; SPINAL CORD;

EID: 20444375332     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2021.11.019     Document Type: Erratum

References (53)

1. S. Arner, N. Rawal, L.L. Gustafsson Clinical experience of long-term treatment with epidural and intrathecal opioids a nationwide survey Acta Anaesthesiol Scand 32 1988 253 259
2. T. Avidor-Reiss, M. Bayewitch, R. Levy, N. Matus-Leibovitch, I. Nevo, Z. Vogel Adenylyl cyclase supersensitization in mu-opioid receptor-transfected Chinese hamster ovary cells following chronic opioid treatment J Biol Chem 270 1995 29732 29738
3. A.E. Belevych, C. Sims, R.D. Harvey ACh-induced rebound stimulation of L-type Ca(2+) current in guinea-pig ventricular myocytes, mediated by Gbetagamma-dependent activation of adenylyl cyclase J Physiol 536 2001 677 692
4. L.M. Bohn, R.R. Gainetdinov, F.T. Lin, R.J. Lefkowitz, M.G. Caron Mu-opioid receptor desensitization by beta-arrestin-2 determines morphine tolerance but not dependence Nature 408 2000 720 723
5. D.W. Bonhaus, L.K. Chang, J. Kwan, G.R. Martin Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists Evidence for agonist-specific trafficking of intracellular responses J Pharmcol Exp Ther 287 1998 884 888
6. 3H-naloxone benzoylhydrazone binding in MOR-1 transfected Chinese hamster ovary cells Evidence for G-protein-dependent antagonist binding J Pharmcol Exp Ther 268 1988 376 381
7. C. Chen, J.C. Xue, J. Zhu, Y.W. Chen, S. Kunapuli, J.K. de Riel, L. Yu, L.Y. Liu-Chen Characterization of irreversible β-funaltrexamine binding to the cloned rat μ-opioid receptor J Biol Chem 270 1995 17866 17870
8. V.L. Chindalore, R.A. Craven, P.G. Butera, K.P. Yu, L.H. Burns, N. Friedmann Adding ultra-low-dose naltrexone to oxycodone enhances and prolongs analgesia J Pain 6 2005 392 399
9. M. Connor, M.D. Christie Opioid receptor signalling mechanisms Clin Exp Pharmacol Physiol 26 1999 493 499
10. S.M. Crain, K.-F. Shen Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons Trends Pharmacol Sci 11 1990 77 81
11. S.M. Crain, K.-F. Shen After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside Brain Res 575 1992 13 24
12. S.M. Crain, K.-F. Shen Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment Proc Natl Acad Sci U S A 92 1995 10540 10544
13. S.M. Crain, K.-F. Shen Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions Trends Pharmacol Sci 19 1998 358 365
14. S.M. Crain, K.-F. Shen Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability Pain 84 2000 121 131
15. S.M. Crain, K.-F. Shen Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia Brain Res 888 2001 75 82
16. R.A. Cruciani, D. Lussier, D. Miller-Saultz, D.M. Arbuck Ultra-low dose oral naltrexone decreases side effects and potentiates the effect of methadone J Pain Symptom Manage 25 2003 491 494
17. Y. Daaka, L.M. Luttrell, R.J. Lefkowitz Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A Nature 390 1997 88 91
18. A.D. Federman, B.R. Conklin, K.A. Schrader, R.R. Reed, H.R. Bourne Hormonal stimulation of adenylyl cyclase through Gi-protein beta gamma subunits Nature 356 1992 159 161
19. S.S. Ferguson, L.S. Barak, J. Zhang, M.G. Caron G-protein-coupled receptor regulation role of G-protein-coupled receptor kinases and arrestins Can J Physiol Pharmacol 74 1996 1095 1110
20. E. Friedman, P. Butkerait, H.-Y. Wang Analysis of receptor-stimulated and basal guanine nucleotide binding to membrane G proteins by sodium dodecyl sulfate-polyacrylamide gel electrophoresis Anal Biochem 214 1993 171 178
21. E. Friedman, H.-Y. Wang Receptor-mediated activation of G proteins is increased in postmortem brains of bipolar affective disorder subjects J Neurochem 67 1996 1145 1152
22. T.J. Gan, B. Ginsberg, P.S.A. Glass, J. Fortney, R. Jhaveri, R. Perno Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate Anesthesiology 87 1997 1075 1081
23. A.R. Gintzler, S. Chakrabarti Opioid tolerance and the emergence of new opioid receptor-coupled signaling Mol Neurobiol 21 2001 21 33
24. S. Hamman, E. Wala, A. Rebel, R. Lock Selective antagonism of excitatory opioid receptor systems A pilot clinical study demonstrating enhancement of morphine analgesia by low-dose naloxone in female patients undergoing elective laparotomy 2004 Proceedings of the American Society of Anesthesiologists, New Orleans, LA
25. K. Ikeda, T. Kobayashi, T. Kumanishi, H. Niki, RY Involvement of G-protein-activated inwardly rectifying K+ (GIRK) channels in opioid-induced analgesia Neurosci Res 38 2000 113 116
26. A. Jarrahian, V.J. Watts, E.L. Barker D2 dopamine receptors modulate Gα -subunit coupling of the CB1 cannabinoid receptor J Pharmacol Exp Ther 308 2004 880 886
27. L.Q. Jin, H.-Y. Wang, E. Friedman Stimulated D(1) dopamine receptors couple to multiple Galpha proteins in different brain regions J Neurochem 78 2001 981 990
28. G.P. Joshi, L. Duffy, J. Chehade, J. Wesevich, N. Gajraj, E.R. Johnson Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia Anesthesiology 90 1999 1007 1011
29. V. Kayser, J.M. Besson, G. Guilbaud Paradoxical hyperalgesic effect of exceedingly low doses of systemic morphine in an animal model of persistent pain (Freund's adjuvant-induced arthritis rats) Brain Res 414 1987 155 157
30. E.A. Kiyatkin Morphine some puzzles of a well-known substance Int J Neurosci 45 1989 231 246
31. H.I. Krieger-Brauer, P. Medda, H. Kather Basic fibroblast growth factor utilizes both types of component subunits of Gs for dual signaling in human adipocytes. Stimulation of adenylyl cyclase via Galph(s) and inhibition of NADPH oxidase by Gbeta gamma(s) J Biol Chem 275 2000 35920 35925
32. K.L. Laugwitz, S. Offermanns, K. Spicher, G. Schultz Mu and delta opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells Neuron 10 1993 233 242
33. F. Leri, L.H. Burns Ultra-low-dose naltrexone reduces rewarding potency of oxycodone and relapse vulnerability in rats 2005 Pharmacol Biochem Beh, in press
34. T. Lewanowitsch, R.J. Irvine Naloxone and its quaternary derivative, naloxone methiodide, have differing affinities for mu, delta, kappa opioid receptors in mouse brain homogenates Brain Res 964 2003 302 305
35. J. MacRae, S. Siegel The role of self-administration in morphine withdrawal in rats Psychobiology 25 1997 77 82
36. E.J. Nestler Molecular neurobiology of addiction Am J Addict 10 2001 201 217
37. M.C. Olmstead, L.H. Burns Ultra-low-dose naltrexone suppresses rewarding effects of opiates and aversive effects of opiate withdrawal in rats 2005 Psychopharmacology, in press
38. K. Oxbro, T. Trang, M. Sutak, K.H. Jhamandas The effects of spinal ultra-low doses of an opioid receptor antagonist on systemic morphine dependence 2003 Proceedings of the Society for Neuroscience, New Orleans, LA
39. K.J. Powell, N.S. Abul-Husn, A. Jhamandas, M.C. Olmstead, R.J. Beninger, K. Jhamandas Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats J Pharmacol Exp Ther 300 2002 588 596
40. L. Robillard, N. Ethier, M. Lachance, T.E. Hebert Gbetagamma subunit combinations differentially modulate receptor and effector coupling in vivo Cell Signal 12 2000 673 682
41. H. Saegusa, T. Kurihara, S. Zong, O. Minowa, A. Kazuno, W. Han, Y. Matsuda, H. Yamanaka, M. Osanai, T. Noda, T. Tanabe Altered pain responses in mice lacking α1E subunit of the voltage-dependent Ca2+ channel Proc Natl Acad Sci U S A 97 2000 6132 6137
42. K.F. Shen, S.M. Crain Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture Brain Res 491 1989 227 242
43. K.F. Shen, S.M. Crain Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence Brain Res 636 1994 286 297
44. K.F. Shen, S.M. Crain Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice Brain Res 757 1997 176 190
45. K.-F. Shen, S.M. Crain Cholera toxin-A subunit blocks opioid excitatory effects on sensory neuron action potentials indicating mediation by Gs-linked opioid receptors Brain Res 525 1990 225 231
46. W.-J. Tang, A.G. Gilman Type specific regulation of adenylyl cyclase by G protein beta gamma subunits Science 254 1991 1500 1503
47. T. Vanderah, M. Ossipov, J. Lai, T. Malan, F. Porreca Mechanisms of opioid-induced pain and antinociceptive tolerance descending facilitation and spinal dynorphin Pain 92 2001 5 9
48. E. Veerman, A. Ligtenberg, L. Schenkels, E. Walgreen-Weterings, A. Nieuw Amerongen Binding of human high-molecular-weight salivary mucins (MG1) to Hemophilus parainfluenzae J Dent Res 74 1995 351 357
49. D. Wang, K.M. Raehal, E.T. Lin, J.J. Lowery, B.L. Kieffer, E.J. Bilsky, W. Sadee Basal signaling activity of mu opioid receptor in mouse brain Role in narcotic dependence J Pharmacol Exp Ther 308 2004 512 520
50. H-Y. Wang, L.H. Burns, E. Friedman Ultra-low-dose naloxone suppresses tolerance-associated alterations in Mu opioid receptor signaling and conformation 2004 Proceedings of the Society for Neuroscience, San Diego, CA
51. L. Wang, A.R. Gintzler Altered mu-opiate receptor-G protein signal transduction following chronic morphine exposure J Neurochem 68 1997 248 254
52. T. Yamamoto, M. Ohno, S. Ueki A selective-opioid agonist, U-50, 488H, blocks the development of tolerance to morphine analgesia in rats Eur J Pharmacol 156 1988 173 176
53. M. Yoshimura, P.H. Wu, P.L. Hoffman, B. Tabakoff Overexpression of type 7 adenylyl cyclase in the mouse brain enhances acute and chronic actions of morphine Mol Pharmacol 58 2000 1011 1016